Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
$40B deal: Teva offers to buy Mylan
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva to Buy Barr for $7.5 Billion, Boosts Generic Lead
Should You Buy Teva Pharmaceutical Industries Ltd (TEVA) Stock on Wednesday?
Teva Pharmaceutical to buy Mexican Drugmaker
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceuticals will pay $420 million in a federal case
Buy, Sell or Hold: Teva Pharmaceutical (TEVA-N) — Stock Predictions at Stockchase
Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com
Teva Pharmaceutical Stock: 3 Reasons To Buy Teva At $10 (NYSE:TEVA) | Seeking Alpha
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Stay on the Sidelines as the Future Looks Potentially Bleak for Teva Stock | InvestorPlace
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/LCGCPK3EYBF3PJZYOYFN26JDWQ.jpg "Teva buying Allergan, drops Mylan bid")
Teva buying Allergan, drops Mylan bid
